![\"James](\"https:\/\/internationalforum.bmj.com\/utrecht\/wp-content\/uploads\/sites\/24\/2024\/11\/James-Hoffman_150px-min.jpg\")
<\/p><\/p>
Senior Vice President for Quality and Safety, Faculty member, St. Jude Children\u2019s Research Hospital; USA<\/em><\/strong><\/p> James M. Hoffman PharmD, MS, is the Senior Vice President for Quality and Safety and a faculty member in the Department of Pharmacy and Pharmaceutical Sciences at St. Jude Children\u2019s Research Hospital in Memphis, Tennessee. In his role, Dr. Hoffman oversees St. Jude\u2019s quality and safety programs. Before taking on his current role in 2022, he was St. Jude\u2019s Chief Patient Safety Officer for seven years. He helps St. Jude conduct robust improvement projects to improve patient care. He is also part of a research team that works to learn how to make care improvements more quickly across multiple children\u2019s hospitals.<\/p> Dr Hoffman was a core member of the team that created St. Jude\u2019s Safe and Sound strategic plan, and he is particularly focused on helping St. Jude become an academic leader in quality, patient safety, and improvement science for children with catastrophic diseases. Through work at St. Jude (PG4KDS Senior Vice President for Quality and Safety, Faculty member, St. Jude Children\u2019s Research Hospital; USAJames M. Hoffman PharmD, MS, is the Senior Vice President for Quality and Safety and a faculty member in the Department of Pharmacy and Pharmaceutical Sciences at St. Jude Children\u2019s Research Hospital in Memphis, Tennessee. In his role, Dr. Hoffman oversees […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-429","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/internationalforum.bmj.com\/utrecht\/wp-json\/wp\/v2\/posts\/429","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/internationalforum.bmj.com\/utrecht\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/internationalforum.bmj.com\/utrecht\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/internationalforum.bmj.com\/utrecht\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/internationalforum.bmj.com\/utrecht\/wp-json\/wp\/v2\/comments?post=429"}],"version-history":[{"count":0,"href":"https:\/\/internationalforum.bmj.com\/utrecht\/wp-json\/wp\/v2\/posts\/429\/revisions"}],"wp:attachment":[{"href":"https:\/\/internationalforum.bmj.com\/utrecht\/wp-json\/wp\/v2\/media?parent=429"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/internationalforum.bmj.com\/utrecht\/wp-json\/wp\/v2\/categories?post=429"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/internationalforum.bmj.com\/utrecht\/wp-json\/wp\/v2\/tags?post=429"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
www.stjude.org\/pg4kds<\/a>)and nationally through the Clinical Pharmacogenetic Implementation Consortium (CPIC https:\/\/cpicpgx.org<\/a>), he is devoted to implementing pharmacogenetics as a patient safety strategy.<\/p>
","protected":false},"excerpt":{"rendered":"